T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID, 2024, Renaud Cezar et al

Discussion in 'Long Covid research' started by Mij, Jan 4, 2024.

  1. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    8,778
    Background: As about 10% of patients with COVID-19 present sequelae, it is important to better understand the physiopathology of so-called long COVID.

    Method: To this aim, we recruited 29 patients hospitalized for SARS-CoV-2 infection and, by Luminex®, quantified 19 soluble factors in their plasma and in the supernatant of their peripheral blood mononuclear cells, including inflammatory and anti-inflammatory cytokines and chemokines, Th1/Th2/Th17 cytokines, and endothelium activation markers. We also measured their T4, T8 and NK differentiation, activation, exhaustion and senescence, T cell apoptosis, and monocyte subpopulations by flow cytometry. We compared these markers between participants who developed long COVID or not one year later.

    Results: None of these markers was predictive for sequelae, except programmed T4 cell death. T4 lymphocytes from participants who later presented long COVID were more apoptotic in culture than those of sequelae-free participants at Month 12 (36.9 ± 14.7 vs. 24.2 ± 9.0%, p = 0.016).

    Conclusions: Our observation raises the hypothesis that T4 cell death during the acute phase of SARS-CoV-2 infection might pave the way for long COVID. Mechanistically, T4 lymphopenia might favor phenomena that could cause sequelae, including SARS-CoV-2 persistence, reactivation of other viruses, autoimmunity and immune dysregulation. In this scenario, inhibiting T cell apoptosis, for instance, by caspase inhibitors, could prevent long COVID.

    https://www.frontiersin.org/articles/10.3389/fimmu.2023.1335352/full
     
    Michelle, Wonko, Lindberg and 2 others like this.
  2. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,094
    Haven't read the study, but am I correct in assuming that they are mainly comparing ICU to non-ICU patients?

    If that's the case, such a study will most likely only answer questions about the severity of acute infections and outcomes associated to the severity of an acute infection rather than anything useful about general LC.
     
    Last edited: Jan 5, 2024
    Michelle, alktipping, shak8 and 2 others like this.
  3. LarsSG

    LarsSG Senior Member (Voting Rights)

    Messages:
    370
    This looks like they went on a fishing expedition by comparing all kinds of things and found one variable that was different.

    Yes, it looks like only one of their ICU patients didn't get LC. So even if they did find something real, it looks more like a result of being the ICU than anything else.
     
    Mij, EndME, Michelle and 2 others like this.

Share This Page